<DOC>
	<DOCNO>NCT02327273</DOCNO>
	<brief_summary>The purpose study evaluate safety profile , tolerability , Pharmacokinetics ( PK ) Pharmacodynamics ( PD ) follow single multiple oral dos BMS-963272 healthy subject .</brief_summary>
	<brief_title>Randomized , Placebo-Controlled , Double-Blind , Ascending Single Multiple Dose Study Evaluate Safety , Tolerability Pharmacokinetics BMS-963272 Healthy Subjects</brief_title>
	<detailed_description>Study Classification : Safety , PK/PD</detailed_description>
	<criteria>For information regard BMS clinical trial participation , please visit www.BMSStudyConnect.com Healthy subject determine clinically significant deviation normal medical history , physical examination , ECGs clinical laboratory determination Body Mass Index ( BMI ) 27 40 kg/m2 inclusive . BMI = weight ( kg ) / [ height ( ) ] 2 Females ( childbearing potential male , age 18 55 year , inclusive . Female subject must document proof childbearing potential Azoospermic male woman childbearing potential ( i.e . postmenopausal surgically sterile ; see section 3.3.3 definition WOCBP ) exempt contraceptive requirement . However , woman must still undergo pregnancy test described section Evidence organ dysfunction clinically significant deviation normal physical examination , vital sign , ECG clinical laboratory determination beyond consistent target population Any follow 12lead electrocardiogram ( ECG ) prior study drug administration , confirm repeat . ) PR ≥ 210 msec ii ) QRS ≥ 120 msec iii ) QT ≥ 500 msec iv ) QTcF ≥ 450 msec Positive urine screen drug abuse Positive blood screen hepatitis C antibody , hepatitis B surface antigen , HIV1 , 2 antibody Moderate anemia ( hemoglobin &lt; 11 g/dL men &lt; 10 g/dL woman ) aspartate aminotransferase ( AST ) &gt; 1.3x ULN alanine aminotransferase ( ALT ) &gt; 1.3x ULN Total bilirubin &gt; 1.3x upper limit normal ( ULN ) estimate glomerular filtration rate ( eGFR ) &lt; 90 ml/min/1.73 m2 ( calculate use CKDEPI formula ) HbA1c &gt; 6.5 % Fasting total cholesterol &gt; 300 mg/dl Fasting triglycerides &gt; 400 mg/dl Systolic blood pressure &gt; 160 mm Hg and/or diastolic blood pressure &gt; 95 mm Hg , confirm repeat measurement History significant drug allergy ( anaphylaxis hepatotoxicity ) . History lactose intolerance</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>subject</keyword>
</DOC>